Skip to content

The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD

RecruitingNot applicableNCT06982573
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.

Study details

Official title
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With End-Stage Renal Disease (ESRD)
Conditions
  • End-Stage Renal Disease
Interventions
  • Device: Effects of applying magnetic stimulation
Sponsor
Bundang CHA Hospital
Start date
2025-08-06
Primary completion
2026-02-19
Sex
All
Age range
from 19 Years
Results posted
No results posted in this snapshot
Countries
South Korea
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Adults aged 19 years or older 2. Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week 3. Back pain intensity of 4 points or higher on the visual analogue scale (VAS) 4. Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) \[14\] 5. Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions Exclusion Criteria: 1. If the pain is due to trauma 2. If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability. 3. Patients with severe neurological illness (e.g. stroke, severe dementia, etc.). 4. Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection 5. Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant) 6. If there are contraindications to magnetic stimulation * Patients with implanted medical devices (e.g. pacemakers) * Metal objects are inserted into the skull * A wound on the skin at the attachment site * History of epilepsy * Cervical pain or musculoskeletal disease * Pregnant and lactating women

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06982573